Expression_NN
of_IN
erythroid-specific_JJ
genes_NNS
in_IN
megakaryoblastic_JJ
disorders_NNS
._.

Currently_RB
available_JJ
data_NNS
indicate_VBP
that_IN
erythroid_JJ
and_CC
megakaryocytic_JJ
differentiation_NN
pathways_NNS
are_VBP
closely_RB
related_JJ
to_TO
each_DT
other_JJ
,_,
and_CC
there_EX
may_MD
exist_VB
progenitor_NN
cells_NNS
common_JJ
to_TO
those_DT
two_CD
lineages_NNS
may_MD
exist_VB
._.

Acute_JJ
megakaryoblastic_JJ
leukemia_NN
-LRB-_-LRB-
AML-M7_NN
-RRB-_-RRB-
and_CC
transient_JJ
myeloproliferative_JJ
disorder_NN
in_IN
Down_NN
's_POS
syndrome_NN
-LRB-_-LRB-
TMD_NN
-RRB-_-RRB-
are_VBP
characterized_VBN
by_IN
rapid_JJ
growth_NN
of_IN
abnormal_JJ
blast_NN
cells_NNS
which_WDT
express_VBP
megakaryocytic_JJ
markers_NNS
._.

These_DT
blast_NN
cells_NNS
express_VBP
lineage-specific_JJ
transcription_NN
factors_NNS
such_JJ
as_IN
GATA-1_NN
common_JJ
to_TO
these_DT
lineages_NNS
and_CC
frequently_RB
express_VBP
erythroid-specific_JJ
mRNAs_NNS
such_JJ
as_IN
gamma-globin_NN
and_CC
erythroid_JJ
delta-aminolevulinate_JJ
synthase_NN
-LRB-_-LRB-
ALAS-E_NN
-RRB-_-RRB-
,_,
indicating_VBG
that_IN
most_JJS
of_IN
the_DT
blasts_NNS
in_IN
M7_NN
and_CC
TMD_NN
cases_NNS
have_VBP
erythroid_JJ
and_CC
megakaryocytic_JJ
phenotypes_NNS
._.

These_DT
results_NNS
suggest_VBP
that_IN
blasts_NNS
in_IN
M7_NN
and_CC
TMD_NN
may_MD
correspond_VB
to_TO
progenitors_NNS
of_IN
both_CC
erythroid_JJ
and_CC
megakaryocytic_JJ
lineages_NNS
._.

